Improve Medical Instruments Co., Ltd. (SHE:300030)

Market Cap	2.29B +19.9%
Revenue (ttm)	509.09M -14.3%
Net Income	-51.34M
EPS	-0.17
Shares Out	309.19M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,958,300
Average Volume	8,878,022
Open	8.35
Previous Close	7.41
Day's Range	7.25 - 8.35
52-Week Range	4.47 - 9.86
Beta	0.60
RSI	39.12
Earnings Date	Apr 9, 2026

About SHE:300030

Improve Medical Instruments Co., Ltd. engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. It provides clinical laboratory products comprising urine, feces, and thrombosis viscoelastic analysis systems; and automatic biosafety decappers; and Q-VELOX, an intelligent molecular diagnostic workstation. The company also offers offers specimen processing equipment, including evacuated blood collection systems, evacuated blood collection tubes, multi-sample...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1996
• Employees: 790
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300030

Financial Performance

In 2024, SHE:300030's revenue was 581.33 million, a decrease of -9.82% compared to the previous year's 644.62 million. Losses were -117.90 million, 86.5% more than in 2023.